DISEASES OF THE PANCREAS - CLINICAL FINDINGS |
Pancreatic
Disease |
Symptoms |
Signs |
Abnormal
Lab Test Results |
Abnormal
Imaging Findings |
Initial Treatment |
General
and Follow-Up Treatment |
Age
Range(s) Typically Found |
Prognosis |
Acute Pancreatitis |
Severe
epigastric pain radiating to back, nausea, vomiting |
Epigastric
tenderness, Cullen’s sign, Grey Turner’s sign |
↑Amylase,
↑Lipase, leukocytosis, ↑CRP, abnormal LFTs |
Enlarged,
inflamed pancreas, peripancreatic fluid collection |
IV
fluids, pain control, NPO, supportive care |
Avoid
alcohol, low-fat diet, manage underlying cause |
Middle-aged
to older adults, younger in gallstone-related cases |
Good
if mild, severe cases can be life-threatening |
Chronic Pancreatitis |
Chronic
abdominal pain, steatorrhea, weight loss |
Epigastric
tenderness, malnutrition, diabetes |
Mildly
↑Amylase, ↑Lipase, low fecal elastase, diabetes |
Pancreatic
atrophy, calcifications, ductal dilatation |
Pain
management, pancreatic enzyme supplements, low-fat diet |
Avoid
alcohol, pancreatic enzyme replacement, diabetes management |
Middle-aged
to older adults, younger in hereditary cases |
Progressive
disease with risk of diabetes and malnutrition |
Diabetes Mellitus Type 1 |
Polyuria,
polydipsia, weight loss, fatigue |
Dehydration,
tachycardia, weight loss |
↓Insulin,
↑Glucose, ↑HbA1c, autoantibodies (GAD, IA-2) |
No
pancreatic abnormalities, atrophy in late stage |
Insulin
therapy |
Lifelong
insulin therapy, monitor for complications |
Childhood,
early adulthood |
Lifelong
management needed, risk of complications |
Diabetes Mellitus Type 2 |
Polyuria,
polydipsia, fatigue, blurred vision |
Obesity,
acanthosis nigricans, hypertension |
↑Glucose,
↑HbA1c, insulin resistance markers |
No
pancreatic abnormalities, pancreatic fat deposition in obesity |
Lifestyle
modification, oral hypoglycemics, insulin if needed |
Glycemic
control monitoring, weight management, cardiovascular risk reduction |
Middle-aged
to older adults, rising in younger populations |
Variable;
controlled with lifestyle and medication, can worsen |
Pancreatic Insufficiency |
Fatty
stools, weight loss, bloating, malnutrition |
Malnutrition,
bloating, vitamin deficiencies |
↓Fecal
elastase, abnormal secretin stimulation test |
Pancreatic
atrophy, malabsorption findings on imaging |
Pancreatic
enzyme replacement, dietary modification |
Monitor
nutritional status, adjust enzyme dosage as needed |
Any
age, more common in chronic pancreatitis or cystic fibrosis |
Good
with enzyme replacement, poor if untreated |
Diabetes Mellitus Type 1 |
Polyuria,
polydipsia, weight loss, fatigue |
Dehydration,
tachycardia, weight loss |
↓Insulin,
↑Glucose, ↑HbA1c, autoantibodies (GAD, IA-2) |
No
pancreatic abnormalities, atrophy in late stage |
Insulin
therapy |
Lifelong
insulin therapy, monitor for complications |
Childhood,
early adulthood |
Lifelong
management needed, risk of complications |
Diabetes Mellitus Type 2 |
Polyuria,
polydipsia, fatigue, blurred vision |
Obesity,
acanthosis nigricans, hypertension |
↑Glucose,
↑HbA1c, insulin resistance markers |
No
pancreatic abnormalities, pancreatic fat deposition in obesity |
Lifestyle
modification, oral hypoglycemics, insulin if needed |
Glycemic
control monitoring, weight management, cardiovascular risk reduction |
Middle-aged
to older adults, rising in younger populations |
Variable;
controlled with lifestyle and medication, can worsen |
Pancreatic Insufficiency |
Fatty
stools, weight loss, bloating, malnutrition |
Malnutrition,
bloating, vitamin deficiencies |
↓Fecal
elastase, abnormal secretin stimulation test |
Pancreatic
atrophy, malabsorption findings on imaging |
Pancreatic
enzyme replacement, dietary modification |
Monitor
nutritional status, adjust enzyme dosage as needed |
Any
age, more common in chronic pancreatitis or cystic fibrosis |
Good
with enzyme replacement, poor if untreated |
|
|
|
|
|
|
|
|
|